{"SPADE_UN_00290": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2003/0208035 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2003_0208035_A1", "Patent Type": "Patent Application", "Publication Date": "2003-11-6", "Family Info": "CA2264567A1,CN1155714C,CN1233290A,DE69731655D1,DE69731655T2,US6864076,WO1998013478A2,WO1998013478A3", "Patent Title": "Antifungal and/or antibacterial peptides, preparation methods, compositions containing same and methods of treating mammals and/or plants.", "Abstract": "The invention concerns peptides derived from helimomicine by substitution of one or several amnio acids, characterised in that the peptides correspond to formula (I) : X 1 , X 2 , X 3 , X 4 , X 5 , X 6 , C 7 , X 8 , X 9 , X 10 , X 11 , X 12 , X 13 , X 14 , X 15 , X 16 , X 17 , C 18 , X 19 , X 20 , X 21 , C 22 , X 23 , X 24, X25, X 26 , X 27 , X 28 , X 29 , X 30 , X 31 , X 32 , X 33 , X 34 , X 35 , X 36 , X 37 , X 38 , X 39 , C 40 , X 41 , C 42 , X 43 , X 44 wherein X 1 , X 17 , X 21 , X 43 are amino acids; X 16 , X 44 are small polar amino acids; X 19 is a large polar amino acid; X 36 is a small or lightly hydophobic amino acid; X 38 is a lightly hydrophobic or small amino acid; the substitutions being such that: at least one of X 1 , X 17 , X 21 , X 43 is a basic or polar, advantageously large polar amino acid, and/or at least one of the amnio acids X 16 , X 44 is a basic amino acid or a large polar amino acid, and/or X 19 is a basic amino acid, and/or at least one of the amino acids X 36 , X 38"}], "Sequence Information": {"SPADE ID": "SPADE_UN_00290", "Peptide Name": "ETD152 (Mutant of ARD1; Heliomicin analogs)", "Source": "Synthetic construct", "Family": "Not found", "Gene": "Not found", "Sequence": "DKLIGSCVWGAVNYTSRCNAECKRRGYKGGHCGSFANVNCWCET", "Sequence Length": 44, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic", "Biological Activity": ["Antimicrobial", "Antifungal"], "Target Organism": "Fungi:Candida albicans IHEM 8060 (MIC50=3.125 µg/ml), Aspergillus fumigatus GASP4707 (MIC50=25 µg/ml).", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "Not included yet", "Binding Target": "Not found", "Linear/Cyclic": "Not included yet", "N-terminal Modification": "Not included yet", "C-terminal Modification": "Not included yet", "Stereochemistry": "Not included yet", "Structure Description": "Not found", "Formula": "C204H312N64O62S6", "Mass": 4845.44, "PI": 8.65, "Net Charge": 4, "Hydrophobicity": -0.44, "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:>10 hour", "Function": "Possess antifungal activity.", "Literature": [{"Title": "Lead optimization of antifungal peptides with 3D NMR structures analysis.", "Pubmed ID": "14978308", "Reference": "Protein Sci. 2004 Mar;13(3)703-713.", "Author": "Landon C, Barbault F, Legrain M, Menin L, Guenneugues M, Schott V, Vovelle F, Dimarcq JL.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=14978308"}], "Frequent Amino Acids": "CGN", "Absent Amino Acids": "MOPQU", "Basic Residues": 7, "Acidic Residues": 3, "Hydrophobic Residues": 13, "Polar Residues": 30, "Positive Residues": 7, "Negative Residues": 3, "Similar Sequences": [{"SPADE_ID": "SPADE_N_02657", "Similarity": 0.9772727272727273, "Sequence": "DKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFANVNCWCET"}, {"SPADE_ID": "SPADE_UN_25470", "Similarity": 0.9772727272727273, "Sequence": "DKLIGSCVWGAVNYTSDCNAECKRRGYKGGHCGSFANVNCWCET"}, {"SPADE_ID": "SPADE_N_07764", "Similarity": 0.975609756097561, "Sequence": "DKLIGSCVWGAVNYTSNCNAECKRRGYKGGHCGSFANVNCW"}]}}}